Does Boosting NAD+ Actually Slow Aging? The Marketing vs. the Science

Few supplements have better marketing than NAD+ boosters. The pitch sounds perfect: a molecule that drops as you age, and a pill that puts it back — sold as the closest thing to a fountain of youth. It's also the rare supplement whose top ingredient was actually banned from store shelves. Here's the honest gap between the lab and the label.

Evidence Tier: 🥉 Bronze — the anti-aging claim rests on mouse data; in humans, we've only confirmed the pills raise a blood level.

📋 Simple Summary

NAD+ is a molecule in every cell that helps turn food into energy and keeps your DNA repaired. Its levels do tend to fall as you age. NMN and NR are "precursors" — raw ingredients your body uses to make more NAD+.

Here's the honest picture. The pills do raise NAD+ levels in your blood — that part is real and backed by several human trials. But "raises a level in your blood" is not the same as "makes you live longer." The lifespan and anti-aging claims come almost entirely from mice, and even that mouse data is newer and mixed.

In fact, a major 2025 review concluded that human trials of these supplements have shown limited benefit so far. And there's a regulatory wrinkle: actual NMN is no longer legal to sell as a supplement in the U.S. — most "NAD+" products on shelves are a different precursor called NR.

So the verdict: real science, oversold headline. The marketing is years ahead of the evidence.

The detailed breakdown continues below for those who want the full science.

What Are NAD+, NMN, and NR?

NAD+ (nicotinamide adenine dinucleotide) is a helper molecule found in every living cell. It is essential for two big jobs: turning food into usable energy, and powering enzymes that repair DNA damage. When NAD+ runs low, both jobs suffer.

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are both "precursors" — think of them as the raw lumber your body uses to build NAD+. You don't take NAD+ directly (it's a big, fragile molecule that doesn't absorb well). You take a precursor and let your cells assemble the NAD+ themselves.

The two precursors are cousins, and they're often lumped together in marketing as "NAD+ boosters." That's the source of a lot of the confusion — and a regulatory wrinkle we'll get to below.

What the Evidence Actually Shows

The part that's real: the pills raise NAD+

Multiple randomized human trials have confirmed that NMN and NR do what the label says at the most basic level — they raise NAD+ levels in the blood. A 2018 trial found NR was well-tolerated and boosted NAD+ metabolism in healthy middle-aged and older adults. A 2023 safety trial pushed NR all the way to 3,000 mg a day and saw blood NAD+ rise up to five-fold — safely, over four weeks.

So if the claim is narrowly "this raises your NAD+ levels," that's a Silver-grade result. It's real.

The part that isn't: "slows aging" and "extends life"

Here's where the marketing outruns the science. The anti-aging and lifespan claims come from mice, not people. And even in mice, the picture is newer and more mixed than the headlines suggest:

A 2024 study — still a preprint, meaning it hasn't passed peer review yet — found that long-term NMN extended median lifespan by about 8.5% in female mice only, while males got metabolic improvements but no lifespan gain. That's a far cry from the "reverses aging" story sold to humans.

And in humans? A 2025 review in Nature Metabolism was blunt: human clinical trials of NAD+ precursors have shown limited efficacy, and the evidence that NAD+ even declines with age in people is sparse and inconsistent. Another 2023 review noted that most of the NMN evidence comes from cells and animals, with a dozen human trials still underway.

In short: the foundational facts that the whole marketing story rests on are thinner than most people realize.

The Regulatory Wrinkle: Why "NMN" Isn't on U.S. Shelves

Here's a detail most "NAD+" marketing skips. In late 2022, the U.S. Food and Drug Administration determined that NMN can no longer be sold as a dietary supplement in the United States. The reason: a pharmaceutical company had already been authorized to study NMN as a new drug, and a substance under investigation as a drug generally can't also be sold as a supplement.

What this means practically: if you see a "NAD+" or "NMN" product at a big retailer, it is almost always NR (the best-known brand is Tru Niagen) or a different precursor — not actual NMN. The two are close cousins, and the evidence for them is similar, but the distinction matters if you're trying to know exactly what you're buying.

The Honest Verdict

What This Means for You

If you're drawn to NAD+ boosters, know exactly what you're paying for. You're buying a demonstrated rise in NAD+ blood levels — not a demonstrated extension of your life. For most people, the honest question is: is that worth the price tag, which for brand-name NR runs higher than almost any other supplement?

The cheaper, better-evidenced ways to support your NAD+ system and your cells' energy machinery are the boring ones: exercise, adequate sleep, and not overeating. Exercise in particular has been shown to improve NAD+ metabolism — for free, with benefits no pill has matched.

If you do choose to try a precursor, NR is the legal, better-studied option in the U.S., and short-term trials suggest it's well-tolerated. Just go in with your eyes open about what the science has — and hasn't — actually shown.

For a deeper dive on each side of this, see our pages on whether NMN actually works and NMN vs. NR.

❓ Frequently Asked Questions

Sources

1. Martens CR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018. PMID: 29599478
2. Vinten KT, et al. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nat Metab. 2025. PMID: 41083806
3. Kane AE, et al. Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner. bioRxiv [Preprint]. 2024. PMID: 38979132
4. Song Q, et al. The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an Update. Adv Nutr. 2023. PMID: 37619764
5. Nadeeshani H, et al. Nicotinamide mononucleotide (NMN) as an anti-aging health product — Promises and safety concerns. J Adv Res. 2021. PMID: 35499054
6. Berven H, et al. NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease. Nat Commun. 2023. PMID: 38016950